Related Experiment Video
Updated: Feb 1, 2026

An In Vitro Model for Studying Cellular Transformation by Kaposi Sarcoma Herpesvirus
Published on: August 25, 2017
Histiocytic Sarcoma Arising From Pediatric Rosai Dorfman Disease: Two Novel Cases and Literature Review
Sam Sirotnikov1, Rajeswari Jayakumar2, Sunita Park3
1Children's National Hospital, Washington, DC, USA.
Abstract:
Rosai-Dorfman Disease (RDD) is an uncommon histiocytic disorder that can affect lymph nodes and/or extranodal sites. It is marked by the accumulation of abnormal histiocytes that demonstrate emperipolesis-the active, non-destructive engulfment of other leukocytes. RDD exhibits considerable variability in clinical presentation, pathology, genetics, treatment response, and patient outcomes. In this report, we describe 2 rare cases of RDD that underwent sarcomatous transformation and harbored MAP2K1 mutations, both of which demonstrated poor responses to multiple lines of therapy. Additionally, we review 3 other similar cases from the literature.
Insights
Rosai-Dorfman Disease (RDD) rarely transforms into sarcoma, especially with MAP2K1 mutations. These cases showed poor response to therapy, highlighting a challenging clinical scenario.
Area of Science:
- Oncology
- Histiocytic Disorders
Background:
- Rosai-Dorfman Disease (RDD) is a rare histiocytic disorder.
- RDD involves abnormal histiocyte accumulation with emperipolesis.
- Clinical presentation and genetics of RDD show significant variability.
Purpose of the Study:
- To describe two rare cases of Rosai-Dorfman Disease with sarcomatous transformation.
- To investigate the role of MAP2K1 mutations in these transformed RDD cases.
- To review similar cases from existing literature.
Main Methods:
- Case report of two patients with RDD and sarcomatous transformation.
- Genetic analysis for MAP2K1 mutations.
- Literature review of similar RDD cases.
Main Results:
- Two rare cases of RDD with sarcomatous transformation were identified.
- Both cases harbored MAP2K1 mutations.
- Patients showed poor response to multiple therapeutic lines.
Conclusions:
- Sarcomatous transformation in RDD is a rare but significant event.
- MAP2K1 mutations may be associated with sarcomatous transformation in RDD.
- These cases indicate a poor prognosis and limited treatment options.
More Related Videos
05:56Implementation of Non-invasive Point of Care Transient Elastography for Evaluation of Liver Disease in Pediatric Populations with Cystic Fibrosis
Published on: August 29, 2025
04:33Spinal Hernia Repair and Cauda Equina Repositioning After Lumbar Decompression under Three-Dimensional Microscopy: A Case Report and Literature Review
Published on: November 8, 2024
Related Concept Videos
Review and Preview
Percentiles are a type of fractile that partition data into...
Review and Preview
Rous Sarcoma Virus (RSV) and Cancer
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
Pharmacokinetics in Pediatric Patients: Drug Excretion
Pharmacokinetics in Pediatric Patients: Drug Distribution
Pharmacokinetics in Pediatric Patients: Drug Metabolism